Mustang Bio MBIO Balance Sheet (2015-2026)

NASDAQ MBIO
$0.53 -0.01 (-2.43%)
As of: Sep 9, 2026 · 3:53 PM EDT
Reported Financials

Mustang Bio Quarterly Balance Sheet

Periods 41 quarters
Latest Jun 2026

Mustang Bio reported total assets of $15.61M and total liabilities of $8.07M for the quarter ended Jun 2026, up 19.7% year over year. This balance sheet covers 41 quarters of results from Dec 2015 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Dec2015 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Accumulated Depreciation
4.48M5.04M5.10M5.15M
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
120.88M109.62M122.22M107.37M91.36M75.66M58.10M15.38M9.56M6.23M1.34M4.27M3.52M6.84M14.23M12.70M19.00M17.27M16.30M15.20M
Receivables - OtherOther Receivables
0.04M0.01M0.03M0.03M0.03M0.00M-0.04M3.65M6.74M0.73M0.24M0.17M0.47M0.22M0.22M0.22M0.22M
Prepaid Assets
1.03M2.04M1.91M1.97M3.05M2.90M3.03M2.84M4.03M1.23M1.17M0.11M0.08M0.20M0.21M0.17M0.16M0.11M0.11M0.25M
Current Assets
121.95M111.71M124.15M109.38M94.45M78.85M61.13M22.58M13.59M11.35M9.24M7.32M6.05M8.61M14.91M13.05M19.36M17.59M
Non-Current Assets
Property, Plant & Equipment (Net)
9.42M9.03M8.47M8.66M8.95M8.44M8.32M3.79M3.50M3.25M2.96M0.47M0.42M0.37M
Other Non-Current Assets
1.00M1.00M1.00M1.00M1.00M1.00M0.75M0.75M0.75M0.83M0.53M0.38M0.38M0.25M
Non-Current Assets
12.76M13.46M12.81M12.53M14.39M13.57M12.48M6.51M6.98M6.40M5.35M1.20M1.14M0.70M
Assets
134.71M125.17M136.96M121.91M108.84M92.42M73.61M29.09M20.57M17.74M14.59M8.52M7.19M9.31M14.91M13.05M19.36M17.59M16.58M15.61M
Liabilities
Current Liabilities
Accounts Payables
9.83M9.74M9.62M10.16M12.81M13.73M11.44M11.68M12.71M14.02M15.01M13.19M12.06M9.49M8.34M7.50M6.91M5.41M5.32M5.38M
Notes Payables
0.30M0.72M0.81M0.45M0.15M0.77M0.60M
Payables
10.13M10.47M10.43M10.61M12.96M14.50M12.04M11.68M12.71M14.02M15.01M13.19M12.06M9.49M8.34M7.50M6.91M5.41M5.32M5.38M
Accumulated Expenses
2.01M2.60M2.09M2.72M3.25M3.47M1.90M2.19M2.64M2.84M1.20M1.87M1.76M1.60M1.51M1.44M1.47M1.63M1.54M1.58M
Other Accumulated Expenses
0.77M0.77M1.00M0.83M1.85M2.30M2.54M2.67M2.81M2.50M2.53M2.50M2.52M2.54M
Short term Debt
Current Leases
0.33M0.35M0.36M0.37M0.59M0.61M0.63M0.41M0.45M0.52M0.57M0.43M0.44M0.46M
Total Current Liabilities
10.46M10.81M10.78M10.98M13.56M15.11M12.67M12.86M14.17M15.37M17.44M15.92M15.04M12.61M11.15M10.00M9.44M7.91M7.84M7.92M
Non-Current Liabilities
Non-Current Debt
26.99M27.15M27.29M27.44M27.58M
Non-Current Deffered Revenue
0.27M0.27M0.27M0.27M0.27M0.27M0.27M0.27M0.27M0.27M0.27M0.27M0.27M0.15M0.15M0.15M0.15M0.15M0.15M0.15M
Operating Leases
1.76M2.00M1.59M1.50M4.00M3.90M3.90M2.65M2.60M1.98M2.40M1.10M1.00M0.90M
Total Liabilities
12.49M12.77M39.63M39.90M44.51M46.15M43.79M15.37M16.56M17.62M19.54M16.85M15.85M13.18M11.30M10.15M9.59M8.06M7.99M8.07M
Shareholder's Equity
Total Debt
0.30M0.72M27.80M27.60M27.45M28.20M28.18M
Common Equity
122.21M112.40M97.33M82.01M64.33M1.00M29.82M13.71M4.01M0.12M-4.94M-8.33M-8.66M-3.87M3.61M2.89M9.77M9.53M8.60M7.54M
Liabilities and Shareholders Equity
134.71M125.17M136.96M121.91M108.84M92.42M73.61M29.09M20.57M17.74M14.59M8.52M7.19M9.31M14.91M13.05M19.36M17.59M16.58M15.61M
Retained Earnings
-231.80M-251.84M-271.64M-290.74M-309.74M-329.37M-346.10M-362.30M-372.40M-380.97M-386.20M-394.40M-395.80M-396.72M-396.90M-397.64M-398.11M-398.64M-399.60M-400.70M